Ben Klinger
About Ben Klinger
Ben Klinger is the Area Vice President of Corporate Accounts at Boston Scientific, with a career spanning various roles in the medical and pharmaceutical industries.
Title
Ben Klinger currently holds the position of Area Vice President, Corporate Accounts at Boston Scientific. He has been in this role since 2017 and works in the Raleigh-Durham, North Carolina Area.
Professional Experience
Ben Klinger has a robust professional background, having worked in various roles across the medical and pharmaceutical industries. His tenure at Boston Scientific includes positions such as Corporate Accounts and Healthcare Solutions Executive (2016-2017), Manager of Business Development and Strategy (2014-2015), Principal Representative for Cardiac Rhythm Management (2005-2007), and Business Development Manager for Heart Failure (2003-2005). Additionally, he held roles at St. Jude Medical, Stryker, Abiomed, and Pfizer, demonstrating a broad expertise in sales, business development, and account management within the healthcare sector.
Education and Expertise
Ben Klinger completed his Bachelor of Arts from the University of Arizona, studying from 1994 to 1998. His educational background, combined with extensive professional experience, has equipped him with the skills needed for strategic alignment, business development, and healthcare solutions management. His expertise includes developing creative value offerings and leading organizational relationship management.
Notable Projects and Initiatives
Ben Klinger executed a Heart Failure care pathway consulting program across a large Integrated Delivery Network (IDN). This initiative led to improved outcomes and efficiencies while reducing costs within the system. He has also managed over $110 million in pan Boston Scientific revenue, achieving a double-digit compound annual growth rate (CAGR) across four IDNs.
Leadership and Strategic Roles
In his role at Boston Scientific, Ben Klinger leads organizational relationship management and RFP contract negotiations across all divisions. He has been instrumental in aligning corporate and divisional strategies with customers' enterprise goals. Additionally, he has driven cross-divisional and cross-functional alignment and communication to achieve overall corporate strategy and mitigate organizational risk.